位置:首页 > 蛋白库 > NMDE3_MOUSE
NMDE3_MOUSE
ID   NMDE3_MOUSE             Reviewed;        1239 AA.
AC   Q01098;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   03-AUG-2022, entry version 189.
DE   RecName: Full=Glutamate receptor ionotropic, NMDA 2C;
DE            Short=GluN2C;
DE   AltName: Full=Glutamate [NMDA] receptor subunit epsilon-3 {ECO:0000303|PubMed:1377365};
DE   AltName: Full=N-methyl D-aspartate receptor subtype 2C;
DE            Short=NMDAR2C;
DE            Short=NR2C {ECO:0000303|PubMed:8987814};
DE   Flags: Precursor;
GN   Name=Grin2c;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=1377365; DOI=10.1038/358036a0;
RA   Kutsuwada T., Kashiwabuchi N., Mori H., Sakimura K., Kushiya E., Araki K.,
RA   Meguro H., Masaki H., Kumanishi T., Arakawa M., Mishina M.;
RT   "Molecular diversity of the NMDA receptor channel.";
RL   Nature 358:36-41(1992).
RN   [2]
RP   SEQUENCE REVISION.
RA   Kashiwabuchi N.;
RL   Submitted (SEP-1994) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   DISRUPTION PHENOTYPE, FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=8987814; DOI=10.1523/jneurosci.16-24-07859.1996;
RA   Kadotani H., Hirano T., Masugi M., Nakamura K., Nakao K., Katsuki M.,
RA   Nakanishi S.;
RT   "Motor discoordination results from combined gene disruption of the NMDA
RT   receptor NR2A and NR2C subunits, but not from single disruption of the NR2A
RT   or NR2C subunit.";
RL   J. Neurosci. 16:7859-7867(1996).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-875 AND SER-881, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [5]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=27922130; DOI=10.1038/srep38321;
RA   Gupta S.C., Ravikrishnan A., Liu J., Mao Z., Pavuluri R., Hillman B.G.,
RA   Gandhi P.J., Stairs D.J., Li M., Ugale R.R., Monaghan D.T., Dravid S.M.;
RT   "The NMDA receptor GluN2C subunit controls cortical excitatory-inhibitory
RT   balance, neuronal oscillations and cognitive function.";
RL   Sci. Rep. 6:38321-38321(2016).
CC   -!- FUNCTION: Component of NMDA receptor complexes that function as
CC       heterotetrameric, ligand-gated ion channels with high calcium
CC       permeability and voltage-dependent sensitivity to magnesium. Channel
CC       activation requires binding of the neurotransmitter glutamate to the
CC       epsilon subunit, glycine binding to the zeta subunit, plus membrane
CC       depolarization to eliminate channel inhibition by Mg(2+)
CC       (PubMed:1377365). Sensitivity to glutamate and channel kinetics depend
CC       on the subunit composition (PubMed:1377365). Plays a role in regulating
CC       the balance between excitatory and inhibitory activity of pyramidal
CC       neurons in the prefrontal cortex (PubMed:27922130). Contributes to the
CC       slow phase of excitatory postsynaptic current, long-term synaptic
CC       potentiation, and learning (PubMed:8987814).
CC       {ECO:0000269|PubMed:1377365, ECO:0000269|PubMed:27922130,
CC       ECO:0000269|PubMed:8987814}.
CC   -!- SUBUNIT: Heterotetramer. Forms heterotetrameric channels composed of
CC       two zeta subunits (GRIN1), and two epsilon subunits (GRIN2A, GRIN2B,
CC       GRIN2C or GRIN2D) (in vitro) (PubMed:1377365). Can also form
CC       heterotetrameric channels that contain at least one zeta subunit
CC       (GRIN1), at least one epsilon subunit, plus GRIN3A or GRIN3B (By
CC       similarity). In vivo, the subunit composition may depend on the
CC       expression levels of the different subunits (Probable). Interacts with
CC       PDZ domains of PATJ and DLG4 (By similarity). Interacts (via PDZ-
CC       binding motif) with SNX27 (via PDZ domain); the interaction is required
CC       for recycling to the plasma membrane when endocytosed and prevent
CC       degradation in lysosomes (By similarity).
CC       {ECO:0000250|UniProtKB:Q00961, ECO:0000250|UniProtKB:Q14957,
CC       ECO:0000269|PubMed:1377365, ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1377365};
CC       Multi-pass membrane protein {ECO:0000305}. Postsynaptic cell membrane;
CC       Multi-pass membrane protein.
CC   -!- TISSUE SPECIFICITY: Detected in cerebellum (at protein level)
CC       (PubMed:8987814). Detected in the granule cell layer of the cerebellum
CC       (PubMed:1377365). {ECO:0000269|PubMed:1377365,
CC       ECO:0000269|PubMed:8987814}.
CC   -!- DOMAIN: A hydrophobic region that gives rise to the prediction of a
CC       transmembrane span does not cross the membrane, but is part of a
CC       discontinuously helical region that dips into the membrane and is
CC       probably part of the pore and of the selectivity filter.
CC       {ECO:0000250|UniProtKB:Q00960}.
CC   -!- DISRUPTION PHENOTYPE: Mutant mice appear grossly normal
CC       (PubMed:8987814). Mossy fiber granule cells from mutant mice present a
CC       decrease of the slow component of the excitatory postsynaptic current
CC       (PubMed:8987814). Pyramidal neurons in the prefrontal cortex display a
CC       reduced dendritic spine density (PubMed:27922130). Besides, the
CC       prefrontal cortex has an altered pattern of excitatory and inhibitory
CC       synapses (PubMed:27922130). Pyramidal neurons in the prefrontal cortex
CC       display a reduced frequency of miniature excitatory postsynaptic
CC       currents (mEPSC), together with an increased frequency of miniature
CC       inhibitory postsynaptic currents (mIPSC), indicative of a shift in the
CC       balance between excitatory and inhibitory membrane currents
CC       (PubMed:27922130). The slow component of the excitatory postsynaptic
CC       current is nearly abolished in mossy fiber cells from mice lacking both
CC       Grin2a and Grin2c (PubMed:8987814). Mice lacking both Grin2a and Grin2c
CC       display subtle motor deficits; they have no visible phenotype when
CC       performing simple tasks, but have decreased ability to walk across a
CC       narrow wooden bar, and are unable to stay on a rapidly rotating rod
CC       (PubMed:8987814). {ECO:0000269|PubMed:27922130,
CC       ECO:0000269|PubMed:8987814}.
CC   -!- SIMILARITY: Belongs to the glutamate-gated ion channel (TC 1.A.10.1)
CC       family. NR2C/GRIN2C subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D10694; BAA01536.1; -; mRNA.
DR   CCDS; CCDS25624.1; -.
DR   PIR; I49705; I49705.
DR   RefSeq; NP_034480.2; NM_010350.2.
DR   AlphaFoldDB; Q01098; -.
DR   SMR; Q01098; -.
DR   BioGRID; 200070; 6.
DR   ComplexPortal; CPX-292; NMDA receptor complex, GluN1-GluN2C.
DR   IntAct; Q01098; 1.
DR   MINT; Q01098; -.
DR   STRING; 10090.ENSMUSP00000102164; -.
DR   ChEMBL; CHEMBL3832634; -.
DR   GlyConnect; 2352; 1 N-Linked glycan (1 site).
DR   GlyGen; Q01098; 6 sites, 1 N-linked glycan (1 site).
DR   iPTMnet; Q01098; -.
DR   PhosphoSitePlus; Q01098; -.
DR   PaxDb; Q01098; -.
DR   PRIDE; Q01098; -.
DR   ProteomicsDB; 293865; -.
DR   ABCD; Q01098; 3 sequenced antibodies.
DR   Antibodypedia; 19474; 286 antibodies from 35 providers.
DR   DNASU; 14813; -.
DR   Ensembl; ENSMUST00000003351; ENSMUSP00000003351; ENSMUSG00000020734.
DR   Ensembl; ENSMUST00000106554; ENSMUSP00000102164; ENSMUSG00000020734.
DR   GeneID; 14813; -.
DR   KEGG; mmu:14813; -.
DR   UCSC; uc007mgx.1; mouse.
DR   CTD; 2905; -.
DR   MGI; MGI:95822; Grin2c.
DR   VEuPathDB; HostDB:ENSMUSG00000020734; -.
DR   eggNOG; KOG1053; Eukaryota.
DR   GeneTree; ENSGT00940000156964; -.
DR   HOGENOM; CLU_002039_1_0_1; -.
DR   InParanoid; Q01098; -.
DR   OMA; VENQARH; -.
DR   OrthoDB; 188544at2759; -.
DR   PhylomeDB; Q01098; -.
DR   TreeFam; TF314731; -.
DR   Reactome; R-MMU-438066; Unblocking of NMDA receptors, glutamate binding and activation.
DR   Reactome; R-MMU-8849932; Synaptic adhesion-like molecules.
DR   Reactome; R-MMU-9609736; Assembly and cell surface presentation of NMDA receptors.
DR   BioGRID-ORCS; 14813; 4 hits in 75 CRISPR screens.
DR   PRO; PR:Q01098; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; Q01098; protein.
DR   Bgee; ENSMUSG00000020734; Expressed in cerebellum lobe and 88 other tissues.
DR   ExpressionAtlas; Q01098; baseline and differential.
DR   Genevisible; Q01098; MM.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISO:MGI.
DR   GO; GO:0017146; C:NMDA selective glutamate receptor complex; IPI:MGI.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0098839; C:postsynaptic density membrane; IBA:GO_Central.
DR   GO; GO:0045211; C:postsynaptic membrane; IC:ComplexPortal.
DR   GO; GO:0005261; F:cation channel activity; IMP:MGI.
DR   GO; GO:0022849; F:glutamate-gated calcium ion channel activity; ISS:UniProtKB.
DR   GO; GO:0004970; F:ionotropic glutamate receptor activity; ISO:MGI.
DR   GO; GO:0015276; F:ligand-gated ion channel activity; IBA:GO_Central.
DR   GO; GO:0004972; F:NMDA glutamate receptor activity; IMP:MGI.
DR   GO; GO:0030165; F:PDZ domain binding; ISO:MGI.
DR   GO; GO:0047485; F:protein N-terminus binding; ISO:MGI.
DR   GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central.
DR   GO; GO:1904315; F:transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0097553; P:calcium ion transmembrane import into cytosol; ISS:UniProtKB.
DR   GO; GO:0098655; P:cation transmembrane transport; IC:ComplexPortal.
DR   GO; GO:0033058; P:directional locomotion; IGI:MGI.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; IMP:MGI.
DR   GO; GO:0035235; P:ionotropic glutamate receptor signaling pathway; ISO:MGI.
DR   GO; GO:0060291; P:long-term synaptic potentiation; IBA:GO_Central.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; IGI:MGI.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IMP:MGI.
DR   GO; GO:2000463; P:positive regulation of excitatory postsynaptic potential; ISO:MGI.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; ISO:MGI.
DR   GO; GO:1903539; P:protein localization to postsynaptic membrane; IMP:MGI.
DR   GO; GO:1904062; P:regulation of cation transmembrane transport; ISO:MGI.
DR   GO; GO:0042391; P:regulation of membrane potential; IMP:MGI.
DR   GO; GO:0048168; P:regulation of neuronal synaptic plasticity; IC:ComplexPortal.
DR   GO; GO:0009611; P:response to wounding; IGI:MGI.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR019594; Glu/Gly-bd.
DR   InterPro; IPR001508; Iono_rcpt_met.
DR   InterPro; IPR001320; Iontro_rcpt.
DR   InterPro; IPR018884; NMDAR2_C.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00060; Lig_chan; 1.
DR   Pfam; PF10613; Lig_chan-Glu_bd; 1.
DR   Pfam; PF10565; NMDAR2_C; 1.
DR   PRINTS; PR00177; NMDARECEPTOR.
DR   SMART; SM00918; Lig_chan-Glu_bd; 1.
DR   SMART; SM00079; PBPe; 1.
DR   SUPFAM; SSF53822; SSF53822; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; Disulfide bond; Glycoprotein; Ion channel;
KW   Ion transport; Ligand-gated ion channel; Magnesium; Membrane;
KW   Phosphoprotein; Postsynaptic cell membrane; Receptor; Reference proteome;
KW   Signal; Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..1239
FT                   /note="Glutamate receptor ionotropic, NMDA 2C"
FT                   /id="PRO_0000011581"
FT   TOPO_DOM        20..554
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TRANSMEM        555..573
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TOPO_DOM        574..600
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   INTRAMEM        601..620
FT                   /note="Discontinuously helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TOPO_DOM        621..627
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TRANSMEM        628..643
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TOPO_DOM        644..814
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TRANSMEM        815..834
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   TOPO_DOM        835..1239
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   REGION          601..620
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   REGION          918..988
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           1237..1239
FT                   /note="PDZ-binding"
FT   COMPBIAS        918..936
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        937..952
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         509..511
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   BINDING         511
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:Q00960"
FT   BINDING         516
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   BINDING         687..688
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   BINDING         729
FT                   /ligand="L-glutamate"
FT                   /ligand_id="ChEBI:CHEBI:29985"
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   SITE            612
FT                   /note="Functional determinant of NMDA receptors"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         875
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         881
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         912
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00961"
FT   CARBOHYD        70
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        73
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        337
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        438
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        539
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        685
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        82..317
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   DISULFID        426..453
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   DISULFID        433..454
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
FT   DISULFID        743..798
FT                   /evidence="ECO:0000250|UniProtKB:Q00959"
SQ   SEQUENCE   1239 AA;  135420 MW;  793E8E731E20C3C9 CRC64;
     MGGALGPALL LTSLLGAWAG LGAGQGEQAV TVAVVFGSSG PLQAQARTRL TPQNFLDLPL
     EIQPLTIGVN NTNPSSILTQ ICGLLGAARV HGIVFEDNVD TEAVAQLLDF VSSQTHVPIL
     SISGGSAVVL TPKEPGSAFL QLGVSLEQQL QVLFKVLEEY DWSAFAVITS LHPGHALFLE
     GVRAVADASY LSWRLLDVLT LELGPGGPRA RTQRLLRQVD APVLVAYCSR EEAEVLFAEA
     AQAGLVGPGH VWLVPNLALG STDAPPAAFP VGLISVVTES WRLSLRQKVR DGVAILALGA
     HSYRRQYGTL PAPAGDCRSH PGPVSPAREA FYRHLLNVTW EGRDFSFSPG GYLVQPTMVV
     IALNRHRLWE MVGRWDHGVL YMKYPVWPRY STSLQPVVDS RHLTVATLEE RPFVIVESPD
     PGTGGCVPNT VPCRRQSNHT FSSGDITPYT KLCCKGFCID ILKKLAKVVK FSYDLYLVTN
     GKHGKRVRGV WNGMIGEVYY KRADMAIGSL TINEERSEII DFSVPFVETG ISVMVARSNG
     TVSPSAFLEP YSPAVWVMMF VMCLTVVAIT VFMFEYFSPV SYNQNLTKGK KSGGPSFTIG
     KSVWLLWALV FNNSVPIENP RGTTSKIMVL VWAFFAVIFL ASYTANLAAF MIQEQYIDTV
     SGLSDKKFQR PQDQYPPFRF GTVPNGSTER NIRSNYRDMH THMVKFNQRS VEDALTSLKM
     GKLDAFIYDA AVLNYMAGKD EGCKLVTIGS GKVFATTGYG IAMQKDSHWK RAIDLALLQF
     LGDGETQKLE TVWLSGICHN EKNEVMSSKL DIDNMAGVFY MLLVAMGLAL LVFAWEHLVY
     WKLRHSVPSS SQLDFLLAFS RGIYSCFNGV QSLPSPARPP SPDLTAGSAQ ANVLKMLQAA
     RDMVSTADVS GSLDRATRTI ENWGNNRRAP APTTSGPRSC TPGPPGQPSP SGWRPPGGGR
     TPLARRAPQP PARPATCAGS PQPDVSRASC RHAWDARWPV RVGHQGSHLS ASERRALPER
     SLLHAHCHYS SFPRAERSGR PFLPLFPEPP EPDDLPLLGP EQLARREALL RAAWARGPRP
     RHASLPSSVA EAFTRSNPLP ARCTGHACAC PCPQSRPSCR HVAQTQSLRL PSYREACVEG
     VPAGVAATWQ PRQHVCLHTH THLPFCWGTV CRHPPPCSSH SPWLIGTWEP PSHRGRTLGL
     GTGYRDSGVL EEVSREACGT QGFPRSCTWR RISSLESEV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024